CPHI vs DGX · rev $4.1M vs P/E 22, rev $9.87B
China Pharma Holdings Inc (CPHI) versus Quest Diagnostics Incorporated (DGX) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported DGX revenue for 2024-12-31 was $9.87B. Net income was $921.0M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
CPHI currently screens at market cap $29.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Not investment advice. Open the CPHI and DGX stock pages for the full models.
Not investment advice.